Erratum to: 18F-Fluorocholine PET/CT for early response assessment in patients with metastatic castration-resistant prostate cancer treated with enzalutamide [Eur J Nucl Med Mol Imaging, DOI 10.1007/s00259-015-3042-5]

Ugo De Giorgi; Paola Caroli; Emanuela Scarpi; Vincenza Conteduca; Salvatore Luca Burgio; Cecilia Menna; Andrea Moretti; Riccardo Galassi; Lorena Rossi; Dino Amadori; Giovanni Paganelli; Federica Matteucci

doi:10.1007/s00259-015-3069-7

Erratum to: ¹⁸F-Fluorocholine PET/CT for early response assessment in patients with metastatic castration-resistant prostate cancer treated with enzalutamide [Eur J Nucl Med Mol Imaging, DOI 10.1007/s00259-015-3042-5]

Ugo De Giorgi, Paola Caroli, Emanuela Scarpi, Vincenza Conteduca, Salvatore Luca Burgio, Cecilia Menna, Andrea Moretti, Riccardo Galassi, Lorena Rossi, Dino Amadori, Giovanni Paganelli, Federica Matteucci

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	1337-1338
Number of pages	2
Journal	European Journal of Nuclear Medicine and Molecular Imaging
Volume	42
Issue number	8
DOIs	https://doi.org/10.1007/s00259-015-3069-7
Publication status	Published - Apr 22 2015

ASJC Scopus subject areas

Radiology Nuclear Medicine and imaging

Access to Document

10.1007/s00259-015-3069-7

Cite this

De Giorgi, U., Caroli, P., Scarpi, E., Conteduca, V., Burgio, S. L., Menna, C., Moretti, A., Galassi, R., Rossi, L., Amadori, D., Paganelli, G., & Matteucci, F. (2015). Erratum to: ¹⁸F-Fluorocholine PET/CT for early response assessment in patients with metastatic castration-resistant prostate cancer treated with enzalutamide [Eur J Nucl Med Mol Imaging, DOI 10.1007/s00259-015-3042-5]. European Journal of Nuclear Medicine and Molecular Imaging, 42(8), 1337-1338. https://doi.org/10.1007/s00259-015-3069-7

Erratum to : ¹⁸F-Fluorocholine PET/CT for early response assessment in patients with metastatic castration-resistant prostate cancer treated with enzalutamide [Eur J Nucl Med Mol Imaging, DOI 10.1007/s00259-015-3042-5]. / De Giorgi, Ugo ; Caroli, Paola ; Scarpi, Emanuela ; Conteduca, Vincenza ; Burgio, Salvatore Luca; Menna, Cecilia; Moretti, Andrea; Galassi, Riccardo; Rossi, Lorena; Amadori, Dino; Paganelli, Giovanni ; Matteucci, Federica.

In: European Journal of Nuclear Medicine and Molecular Imaging, Vol. 42, No. 8, 22.04.2015, p. 1337-1338.

Research output: Contribution to journal › Article › peer-review

De Giorgi, U , Caroli, P , Scarpi, E , Conteduca, V , Burgio, SL, Menna, C, Moretti, A, Galassi, R, Rossi, L, Amadori, D, Paganelli, G & Matteucci, F 2015, 'Erratum to: ¹⁸F-Fluorocholine PET/CT for early response assessment in patients with metastatic castration-resistant prostate cancer treated with enzalutamide [Eur J Nucl Med Mol Imaging, DOI 10.1007/s00259-015-3042-5]', European Journal of Nuclear Medicine and Molecular Imaging, vol. 42, no. 8, pp. 1337-1338. https://doi.org/10.1007/s00259-015-3069-7

De Giorgi U , Caroli P , Scarpi E , Conteduca V , Burgio SL, Menna C et al. Erratum to: ¹⁸F-Fluorocholine PET/CT for early response assessment in patients with metastatic castration-resistant prostate cancer treated with enzalutamide [Eur J Nucl Med Mol Imaging, DOI 10.1007/s00259-015-3042-5]. European Journal of Nuclear Medicine and Molecular Imaging. 2015 Apr 22;42(8):1337-1338. https://doi.org/10.1007/s00259-015-3069-7

De Giorgi, Ugo ; Caroli, Paola ; Scarpi, Emanuela ; Conteduca, Vincenza ; Burgio, Salvatore Luca ; Menna, Cecilia ; Moretti, Andrea ; Galassi, Riccardo ; Rossi, Lorena ; Amadori, Dino ; Paganelli, Giovanni ; Matteucci, Federica. / Erratum to : ¹⁸F-Fluorocholine PET/CT for early response assessment in patients with metastatic castration-resistant prostate cancer treated with enzalutamide [Eur J Nucl Med Mol Imaging, DOI 10.1007/s00259-015-3042-5]. In: European Journal of Nuclear Medicine and Molecular Imaging. 2015 ; Vol. 42, No. 8. pp. 1337-1338.

@article{beb0f8d7ab944b2fbdc5dbdfb5332593,

title = "Erratum to: 18F-Fluorocholine PET/CT for early response assessment in patients with metastatic castration-resistant prostate cancer treated with enzalutamide [Eur J Nucl Med Mol Imaging, DOI 10.1007/s00259-015-3042-5]",

author = "{De Giorgi}, Ugo and Paola Caroli and Emanuela Scarpi and Vincenza Conteduca and Burgio, {Salvatore Luca} and Cecilia Menna and Andrea Moretti and Riccardo Galassi and Lorena Rossi and Dino Amadori and Giovanni Paganelli and Federica Matteucci",

year = "2015",

month = apr,

day = "22",

doi = "10.1007/s00259-015-3069-7",

language = "English",

volume = "42",

pages = "1337--1338",

journal = "European Journal of Pediatrics",

issn = "0340-6199",

publisher = "Springer Berlin Heidelberg",

number = "8",

}

TY - JOUR

T1 - Erratum to

T2 - 18F-Fluorocholine PET/CT for early response assessment in patients with metastatic castration-resistant prostate cancer treated with enzalutamide [Eur J Nucl Med Mol Imaging, DOI 10.1007/s00259-015-3042-5]

AU - De Giorgi, Ugo

AU - Caroli, Paola

AU - Scarpi, Emanuela

AU - Conteduca, Vincenza

AU - Burgio, Salvatore Luca

AU - Menna, Cecilia

AU - Moretti, Andrea

AU - Galassi, Riccardo

AU - Rossi, Lorena

AU - Amadori, Dino

AU - Paganelli, Giovanni

AU - Matteucci, Federica

PY - 2015/4/22

Y1 - 2015/4/22

UR - http://www.scopus.com/inward/record.url?scp=84932196533&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84932196533&partnerID=8YFLogxK

U2 - 10.1007/s00259-015-3069-7

DO - 10.1007/s00259-015-3069-7

M3 - Article

AN - SCOPUS:84932196533

VL - 42

SP - 1337

EP - 1338

JO - European Journal of Pediatrics

JF - European Journal of Pediatrics

SN - 0340-6199

IS - 8

ER -

Erratum to: 18F-Fluorocholine PET/CT for early response assessment in patients with metastatic castration-resistant prostate cancer treated with enzalutamide [Eur J Nucl Med Mol Imaging, DOI 10.1007/s00259-015-3042-5]

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this

Erratum to: ¹⁸F-Fluorocholine PET/CT for early response assessment in patients with metastatic castration-resistant prostate cancer treated with enzalutamide [Eur J Nucl Med Mol Imaging, DOI 10.1007/s00259-015-3042-5]